China Shineway Pharmaceutical Group Limited

CSWYY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$6,140,153$5,888,776$5,026,265$4,205,722
Short-Term Investments$350,020$20,000$3,693$4,323
Receivables$1,201,877$1,260,367$975,062-$4,323
Inventory$813,190$897,709$657,659$587,956
Other Curr. Assets$93,283$87,878$1,078,245$905,434
Total Curr. Assets$8,598,523$8,154,730$6,782,399$5,699,112
Property Plant & Equip (Net)$1,219,402$1,205,287$1,216,937$1,251,999
Goodwill$165,956$165,956$165,956$165,956
Intangibles$23,323$32,790$47,348$66,426
Long-Term Investments$0$0$1,411,020$1,463,916
Tax Assets$34,326$15,230$19,221$20,465
Other NC Assets$0$0-$1,430,241-$1,484,381
Total NC Assets$1,443,007$1,419,263$1,430,241$1,484,381
Other Assets$0$0$19,221$20,465
Total Assets$10,041,530$9,573,993$8,231,861$7,203,958
Liabilities
Payables$402,964$484,791$308,745$228,620
Short-Term Debt$338,271$300,971$6,530$7,587
Tax Payable$84,270$142,169$107,794$65,096
Deferred Revenue$0$0-$6,530-$7,587
Other Curr. Liab.$1,624,491$1,505,787$1,242,524$797,068
Total Curr. Liab.$2,449,996$2,433,718$1,665,593$1,098,371
LT Debt$8,256$355$912$7,324
Deferred Rev, NC$81,853$88,888$163,986$171,594
Deferred Tax Liab, NC$34,521$16,264$18,844$25,188
Other NC Liab.$0$0$0$0
Total NC Liab.$124,630$105,507$183,742$204,106
Other Liabilities$0$0$0$0
Cap. Leases$16,527$1,326$7,442$14,911
Total Liabilities$2,574,626$2,539,225$1,849,335$1,302,477
Equity
Pref Stock$0$0$0$0
Common Stock$87,662$87,662$87,662$87,662
Retained Earnings$6,726,436$6,326,282$6,367,615$5,878,999
AOCI$0$0-$494,891-$487,320
Other Equity$652,806$620,824$422,140$422,140
Total Equity$7,466,904$7,034,768$6,382,526$5,901,481
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,041,530$9,573,993$8,231,861$7,203,958
Net Debt-$5,793,626-$5,587,450-$5,018,823-$4,190,811